You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

idarubicin

Showing 51 - 75 of 160
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in Houston (Decitabine, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 28, 2019

Acute Myeloid Leukemia Trial in Spain (Quizartinib, Placebo oral tablet, Cytarabine)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Santiago De Compostela, A Coruña, Spain
  • +44 more
Jan 20, 2022

Leukemia, Myeloid, Acute Trial in United States (DFP-10917, Cytarabine, Azacitidine)

Recruiting
  • Leukemia, Myeloid, Acute
  • Birmingham, Alabama
  • +38 more
Dec 25, 2021

Acute Promyelocytic Leukemia Trial in Houston (All-Trans Retinoic Acid (ATRA), Arsenic Trioxide (ATO), Idarubicin)

Completed
Has Results
  • Acute Promyelocytic Leukemia
  • All-Trans Retinoic Acid (ATRA)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 23, 2019

Newly Diagnosed AML With FLT3 Activating Mutations Trial in United States (crenolanib, cytarabine, daunorubicin)

Completed
  • Newly Diagnosed AML With FLT3 Activating Mutations
  • Duarte, California
  • +8 more
Jul 17, 2020

Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

Completed
  • Leukemia
  • arsenic trioxide
  • +5 more
  • Innsbruck, Austria
  • +109 more
Oct 10, 2022

Acute Myeloid Leukemia Trial in Ann Arbor, Houston (LY2181308 sodium, cytarabine, idarubicin)

Completed
Has Results
  • Acute Myeloid Leukemia
  • LY2181308 sodium
  • +2 more
  • Ann Arbor, Michigan
  • +1 more
Aug 26, 2019

Acute Myeloid Leukemia Trial in Tianjin (Idarubicin, Cytarabine, Cyclophosphamide)

Unknown status
  • Acute Myeloid Leukemia
  • Idarubicin
  • +3 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 21, 2019

Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

Active, not recruiting
Has Results
  • Childhood Acute Promyelocytic Leukemia (M3)
  • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
  • arsenic trioxide
  • +7 more
  • Birmingham, Alabama
  • +110 more
Mar 23, 2022

Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations Trial in Worldwide (Crenolanib, Cytarabine,

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations
  • Sacramento, California
  • +61 more
Apr 28, 2021

Acute Myeloid Leukemia Trial in Houston (Clofarabine, Idarubicin, Cytarabine)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 10, 2018

Leukemia Trial in Italy (cytarabine, etoposide, everolimus)

Unknown status
  • Leukemia
  • Bari, Italy
  • +4 more
Oct 22, 2018

AML Trial in Berne (Epacadostat, Idarubicin, Cytarabine)

Withdrawn
  • AML
  • Berne, Switzerland
    Departement of Medical Oncology, University Hospital Berne
Sep 7, 2018

Leukemia Trial in Houston (drug, radiation, biological)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
May 22, 2019

Leukemia, Acute Myeloid Leukemia, AML Trial in Houston (Cytarabine, Idarubicin)

Completed
Has Results
  • Leukemia
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 23, 2018

Relapsed/Refractory Acute Myeloid Leukemia (AML) Trial in United States (Crenolanib, Mitoxantrone, Cytarabine)

Completed
  • Relapsed/Refractory Acute Myeloid Leukemia (AML)
  • Little Rock, Arkansas
  • +3 more
May 8, 2019

AML, Acute Myeloid Leukemia, Myelodysplastic Disorders Trial in Houston (Idarubicin, Sorafenib, Ara-C)

Completed
Has Results
  • AML
  • +2 more
  • Idarubicin
  • +2 more
  • Houston, Texas
    The University of Texas M.D. Anderson Cancer Center
Jul 23, 2018

Leukemia, Myeloid, Acute Trial in Australia, Ireland, United States (GMI-1271, Mitoxantrone, Etoposide)

Completed
  • Leukemia, Myeloid, Acute
  • Sacramento, California
  • +7 more
May 13, 2019

Leukemia Trial in Houston (E7070, Idarubicin, Cytarabine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 4, 2018

Childhood Acute Lymphoblastic Leukemia Trial in Worldwide (Dexamethasone continuous, Dexamethasone intermittent, Dexamethasone)

Recruiting
  • Childhood Acute Lymphoblastic Leukemia
  • Dexamethasone continuous
  • +9 more
  • Ereván, Armenia
  • +57 more
Feb 4, 2020

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 21, 2020

Lymphoma Trial in Houston, Sao Paulo, Santiago (bleomycin sulfate, CHOP regimen, cisplatin)

Completed
  • Lymphoma
  • bleomycin sulfate
  • +13 more
  • Houston, Texas
  • +2 more
Nov 13, 2018

Recurrent Adult Acute Myeloid Leukemia Trial in Palo Alto (Cytarabine, Ibrutinib, Idarubicin)

Terminated
  • Recurrent Adult Acute Myeloid Leukemia
  • Palo Alto, California
    Stanford University, School of Medicine
May 7, 2018

Lymphoma Trial in Houston (biological, drug, procedure, radiation)

Completed
  • Lymphoma
  • Bleomycin Sulfate (BLM)
  • +17 more
  • Houston, Texas
    University of Texas - MD Anderson Cancer Center
Nov 13, 2018

AML Trial in Boston (Volasertib, Cytarabine, Idarubicin)

Withdrawn
  • AML
  • Boston, Massachusetts
  • +1 more
May 3, 2018